Clinical Trial Update: Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover) [Phase 2]

View source ↗

Summary

A Phase 2 rollover safety study of ENT-01 for Parkinson's disease-related constipation was terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Parkinson Disease

Drugs mentioned

• ENT-01

Snippet

Sponsor: Enterin Inc. | Conditions: Parkinson Disease, Constipation | Phase 2 | Status: TERMINATED | Results posted: 2024-03-19